Inflammatory bowel disease is associated with increased mucosal levels of bactericidal/permeability-increasing protein

doi:10.1053/gast.1996.v110.pm8608882

Gastroenterology

Volume 110, Issue 3, March 1996, Pages 733-739

https://doi.org/10.1053/gast.1996.v110.pm8608882 Get rights and content

Abstract

BACKGROUND & AIMS: Clinical sepsis seldom accompanies inflammatory bowel disease. The aim of this study was to measure colonic mucosal levels of the neutrophil product bactericidal/permeability-increasing protein (BPI), which kills gram-negative bacteria in addition to inactivating endotoxin. METHODS: Enzyme-linked immunosorbent assay and immunohistochemistry for BPI were performed on homogenates and tissue secretions of biopsy specimens from patients with ulcerative colitis (n=11) and Crohn's disease (n=5) and from normal controls (n=5). RESULTS: Mucosal neutrophil content (144 +/- 23 vs. 35 +/- 9 neutrophils/mg protein; P<0.007) and BPI content (2.07 +/- 0.75 vs. 0.12 +/- 0.02 ng/mg protein; P<0.002) were greater in the colitis groups and correlated closely (r=0.68; P<0.001). This relationship held for both ulcerative colitis (P<0.002) and Crohn's disease (P<0.01) with a trend towards greater levels in Crohn's disease. There was a trend towards higher BPI levels with an increasing endoscopic inflammation score (grade I, 1.32 +/- 0.6 ng/mg protein; grade II, 2.82 +/- 1.4 ng/mg protein). Immunohistochemistry and the biopsy culture showed BPI to be both intracellular and extracellular, to be present in the crypt lumen, and to be released into incubating medium. CONCLUSIONS: Mucosal levels of BPI are increased in colitis. Such localization may ameliorate mucosal responses to gram-negative bacteria and their products. (Gastroenterology 1996 Mar;110(3):733-9)

References (0)

Cited by (72)

Multifunctional hydrogels based on chitosan, hyaluronic acid and other biological macromolecules for the treatment of inflammatory bowel disease: A review
2023, International Journal of Biological Macromolecules
Hydrogel is a three-dimensional network polymer material rich in water. It is widely used in the biomedical field because of its unique physical and chemical properties and good biocompatibility. In recent years, the incidence of inflammatory bowel disease (IBD) has gradually increased, and the disadvantages caused by traditional drug treatment of IBD have emerged. Therefore, there is an urgent need for new treatments to alleviate IBD. Hydrogel has become a potential therapeutic platform. However, there is a lack of comprehensive review of functional hydrogels for IBD treatment. This paper first summarizes the pathological changes in IBD sites. Then, the action mechanisms of hydrogels prepared from chitosan, sodium alginate, hyaluronic acid, functionalized polyethylene glycol, cellulose, pectin, and γ-polyglutamic acid on IBD were described from aspects of drug delivery, peptide and protein delivery, biologic therapies, loading probiotics, etc. In addition, the advanced functions of IBD treatment hydrogels were summarized, with emphasis on adhesion, synergistic therapy, pH sensitivity, particle size, and temperature sensitivity. Finally, the future development direction of IBD treatment hydrogels has been prospected.
Self-assembled micelle derived from pterostilbene ameliorate acute inflammatory bowel disease
2023, International Journal of Pharmaceutics
Citation Excerpt :
The drug delivery system promoted precise targeting of inflammatory sites based on the specificity of the diseased tissues. Inflammation of the colonic mucosa led to the depletion of the mucus layer and the accumulation of positively charged proteins such as transferrin (Tirosh et al., 2009), bactericidal/permeability increasing proteins, and antimicrobial peptides (Canny et al., 2002; Monajemi et al., 1996; Ramasundara et al., 2009; Wehkamp et al., 2002). This triggered the accumulation of positive charges on the surface of damaged epithelial cells, making nanoparticles with negative surface charges more inclined to accumulate at sites of colonic inflammation (Jubeh et al., 2004; Jubeh et al., 2006).
PEGylated pterostilbene micelle (PTENPs) with higher bioavailability, biocompatibility, and water solubility were prepared. Then we detected the therapeutic effects in the treatment of inflammatory bowel disease (IBD), together with its potential mechanisms. The anti-oxidant effects and anti-inflammatory effects of PTENPs were determined under in vitro and in vivo conditions. Besides, the cellular toxicity of the PTENPs was determined in vitro, and biocompatibility testing was performed on a colitis mice model to determine its safety. The self-assembled PTENPs showed potency in treating IBD, which was featured by effectively anti-oxidant capacity, inhibition of cellular damages, and an anti-inflammatory role. In addition, PTENPs could inhibit the activation of TLR4, thereby inhibiting the NF-κB and MAPK signaling pathways. Meanwhile, it could protect colonic tissues from oxidative damage, which promoted the remission of colonic inflammation with low toxicity. Compared with free PTE, PTENPs could effectively ameliorate acute IBD with low toxicity, which may be related to the inactivation of TLR4, and inhibition of NF-κB and MAPK signaling pathways.
ROS responsive polydopamine nanoparticles to relieve oxidative stress and inflammation for ameliorating acute inflammatory bowel
2022, Biomaterials Advances
Citation Excerpt :
In fact, large amounts of ROS accumulate at the inflammatory lesion, which will significantly induce oxidative damage and increase the expression of inflammatory mediators in the colon [36,37]. In addition, the mucus layer could be massively lost at the inflammatory lesions and accumulate positively charged proteins, including transferrin, permeability-enhancing proteins (BMPs), and antimicrobial peptides (AMPs), ultimately leading to the impaired intestinal barrier function [38–40]. Because of the positively charged surface of inflamed colon tissue, ROS-responsive nanomedicines with negative electrical properties could be the favorable candidates to enhance the target delivery of inflammation lesions, effectively scavenge the excessive ROS and reduce the undesirable drug toxicity.
Oxidative stress is a key factor in the development of inflammatory diseases. Elimination of reactive oxygen species (ROS) in the inflamed colon has been confirmed as an effective strategy to alleviate inflammatory bowel disease (IBD). The conventional approaches will cause systemic absorption and potential side effects. To address these issues, we develop a nanomedicine (LS@PDA NPs) that is capable of delivering to target inflammatory lesions by electrostatic adsorption, subsequently effectively scavenging the excess ROS and alleviating inflammation to ameliorate ulcerative colitis (UC). In the DSS induced acute colitis mice model, LS@PDA NPs can significantly reduce the production of pro-inflammatory cytokines, alleviate oxidative stress, and promote the favorable recovery of the damaged colonic tissue. These results indicate that LS@PDA NPs are able to effectively alleviate intestinal inflammation and provide strong theoretical support for the treatment of other inflammatory diseases.
Colonic delivery of surface charge decorated nanocarrier for IBD therapy
2022, Journal of Drug Delivery Science and Technology
More than 5 million people are living with intestinal inflammation worldwide and treatment with conventional dosage forms has several limitations such as serious adverse effects, inconsistent efficacy, and lack of targeting to the inflamed tissue. Nanocarriers for such therapy present several advantages over conventional ones including targeting drugs selectively to inflamed tissues in a controlled way, thereby decreasing the systemic toxicity levels of the incorporated drugs. However, burst drug release and drug leakage from the nanocarriers might offer challenges to the effective delivery of the drug to a specific colonic location. These problems may be solved through the decoration of nanocarriers with surface charge. The surface charge decorated nanocarriers can precisely target inflamed tissue by electrostatic interaction. In this review we will be discussing the most recent developments in the creation of surface charge adorned nanocarriers for the regulation of Intestinal Bowel Disease (IBD).
Targeted delivery of Chinese herb pair-based berberine/tannin acid self-assemblies for the treatment of ulcerative colitis
2022, Journal of Advanced Research
Ulcerative colitis (UC) is a chronic recurrent idiopathic disease characterized by damage to the colonic epithelial barrier and disruption of inflammatory homeostasis. At present, there is no curative therapy for UC, and the development of effective and low-cost therapies is strongly advocated.
Multiple lines of evidence support that tannic acid (TA) and berberine (BBR), two active ingredients derived from Chinese herb pair (Rhei Radix et Rhizoma and Coptidis Rhizoma), have promising therapeutic effects on colonic inflammation. This study aims to develop a targeted delivery system based on BBR/TA-based self-assemblies for the treatment of UC.
TA and BBR self-assemblies were optimized, and hyaluronic acid (HA) was coated to achieve targeted colon delivery via HA-cluster of differentiation 44 (CD44) interactions. The system was systematically characterized and dextran sodium sulfate (DSS)-induced mouse colitis model was further used to investigate the biodistribution behavior, effect and mechanism of the natural system.
TA and BBR could self-assemble into stable particles (TB) and HA-coated TB (HTB) further increased cellular uptake and accumulation in inflamed colon lesions. Treatment of HTB inhibited pro-inflammatory cytokine levels, restored expression of tight junction-associated proteins and recovered gut microbiome alteration, thereby exerting anti-inflammatory effects against DSS-induced acute colitis.
Our targeted strategy may provide a convenient and powerful platform for UC and reveal new modes of application of herbal combinations.
A KPV-binding double-network hydrogel restores gut mucosal barrier in an inflamed colon
2022, Acta Biomaterialia
Citation Excerpt :
In the present study, a double-network hydrogel (PMSP) was constructed from maleimided γ-polyglutamic acid (PGA-MAL) and thiolated γ-polyglutamic acid (PGA-SH) through crosslinking of thiol-maleimide and self-oxidized thiols. PMSP, which is expected to possess a negative charge due to excess residual carboxyl groups inside the hydrogel, specifically adhered to the inflamed mucosa with positively charged proteins such as transferrin, antimicrobial peptides, and bactericidal/permeability enhancing proteins [25–28]. KPV as a cationic model drug is expected to bind to PMSP through electrostatic interactions to improve its stability in vitro/in vivo.
Ulcerative colitis (UC) usually occurs in the superficial mucosa of the colorectum. Here, a double-network hydrogel (PMSP) was constructed from maleimided γ-polyglutamic acid and thiolated γ-polyglutamic acid through crosslinking of thiol-maleimide and self-oxidized thiols. PMSP with a negative charge specifically adhered to the inflamed mucosa with positively charged proteins rather than to the healthy mucosa. PMSP exhibited good mechanical strength with storage modulus (G′) of 17.6 Pa and a linear viscoelastic region (LVR) of 107.2% strain. Moreover, PMSP showed a stronger bio-adhesive force toward the inflamed tissue-mimicking substrate than toward its healthy counterpart. In vivo imaging confirmed that PMSP specifically adhered to the inflamed colonic mucosa of rats with TNBS-induced UC. KPV (Lys-Pro-Val) as a model drug was easily captured by PMSP through electrostatic interactions, thus retaining its bioactivity for a longer time under high temperature conditions. Moreover, the alleviating effect of KPV on rats with TNBS-induced colitis was significantly improved by PMSP after intracolonic administration. The epithelial barrier of the colon also effectively recovered following PMSP-KPV treatment. PMSP-KPV also modulated the gut flora, markedly augmenting the abundance of beneficial microorganisms in gut homeostasis. The mechanism by which PMSP-KPV induces a therapeutic effect may be associated with the inhibition of oxidative stress. Conclusively, the PMSP hydrogel seems to be a promising rectal delivery system for the therapy of UC.
Ulcerative colitis (UC) is a chronic and relapsing disease of the gastrointestinal tract. A key therapeutic approach to treat UC is to repair the mucosal barriers. Here, a double-network hydrogel (PMSP) was constructed from maleimided and thiolated γ-polyglutamic acid through crosslinking of thiol-maleimide and self-oxidized thiols. The negatively charged PMSP specifically adhered to the inflamed colon rather than its healthy counterpart and was retained for a longer time. KPV as a model drug was easily captured by PMSP, which provided better stability to KPV when exposed to high temperature of 50 °C. The epithelial mucosal barrier of the colon was effectively recovered by the rectal administration of PMSP-KPV to rats with TNBS-induced UC. Moreover, PMSP-KPV modulated the gut flora of colitic rats, markedly augmenting the abundance of beneficial microorganisms. Conclusively, PMSP seems to be a promising rectal delivery system for UC therapy.

View all citing articles on Scopus

View full text